Transplant Nephrologists' Preferences for Clinical Decision Support for APOL1 Genetic Testing of Living Kidney Donors: A Focus Group Study

KEY POINTS: Opportunities exist for clinical decision support (CDS) to help transplant nephrologists counsel living donors receiving apolipoprotein L1 (APOL1) genetic test results. CDS for APOL1 genetic test results should provide access to patient education materials and reminders at follow-up appo...

Descripción completa

Detalles Bibliográficos
Autores principales: Rasmussen, Luke V., Agrawal, Akansha H., Gordon, Elisa J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Nephrology 2023
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10695637/
http://dx.doi.org/10.34067/KID.0000000000000265
Descripción
Sumario:KEY POINTS: Opportunities exist for clinical decision support (CDS) to help transplant nephrologists counsel living donors receiving apolipoprotein L1 (APOL1) genetic test results. CDS for APOL1 genetic test results should provide access to patient education materials and reminders at follow-up appointments. Optimal APOL1 CDS would notify providers when results are available, provide information on follow-up appointments, and provide access to patient education materials. PODCAST: This article contains a podcast at https://dts.podtrac.com/redirect.mp3/www.asn-online.org/media/podcast/K360/2023_12_01_KID0000000000000265.mp3

Ejemplares similares